BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
T cell differentiation
,
Leukemia
,
Liver
,
Early pregnancy factor
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MD 1
Summary
General Info
Curated Studies
Most Correlated Studies
Myelodysplastic syndrome (MDS) in Crebbp +/- mice
PBMC of patients with major depression (MD) or subsyndromal symptomatic depression (SSD)
Bone marrow CD34+ progenitor cells from myelodysplastic syndrome (MDS) patients
Mesenchymal stromal cells of myelodysplastic syndrome (MDS) patients - RCMD and RAEB subtypes
CD34+ peripheral blood cells from MDS and AML patients treated with 5-azacytidine and entinostat
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss of MD1 Promotes Inflammatory and Apoptotic Atrial Remodelling in Diabetic Cardiomyopathy by Act…
Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis.
Genetic variability of immune-related lncRNAs: polymorphisms in LINC-PINT and LY86-AS1 are associate…
MD1 deletion exaggerates cardiomyocyte autophagy induced by heart failure with preserved ejection fr…
Integrating GWAS with bulk and single-cell RNA-sequencing reveals a role for LY86 in the anti-Candid…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia
A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia
VALIDATION OF A PREDICTIVE MODEL OF RESPONSE TO ROMIPLOSTIM IN PATIENTS WITH IPSS LOW OR INTERMEDIAT…
Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS …
Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ